US Stock MarketDetailed Quotes
PMD Psychemedics
- 2.340
- 0.0000.00%
Close Nov 26 16:00 ET
- 2.340
- 0.0000.00%
Post 20:01 ET
13.79MMarket Cap-4588P/E (TTM)
2.345High2.330Low11.67KVolume2.340Open2.340Pre Close27.24KTurnover0.27%Turnover RatioLossP/E (Static)5.89MShares3.93052wk High2.53P/B10.24MFloat Cap1.63052wk Low--Dividend TTM4.38MShs Float22.737Historical High--Div YieldTTM0.63%Amplitude1.630Historical Low2.333Avg Price1Lot Size
Psychemedics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 127.45%263K | 112.51%120K | -110.22%-473K | -130.27%-1.48M | -65.05%662K | -141.05%-958K | -402.52%-959K | -165.22%-225K | 1,081.16%4.89M | 235.22%1.89M |
| Net income from continuing operations | 74.51%-535K | -13.91%-827K | -79.17%-688K | -283.21%-4.15M | -37.35%-945K | -2,063.92%-2.1M | -114.79%-726K | -1,084.62%-384K | -63.01%-1.08M | 57.56%-688K |
| Operating gains losses | ---- | ---- | ---- | --131K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -33.87%453K | -4.60%664K | -22.83%551K | -19.48%2.67M | -24.54%575K | -17.17%685K | -19.72%696K | -16.98%714K | -10.14%3.32M | -11.29%762K |
| Deferred tax | --0 | --0 | --0 | 230.13%691K | -102.87%-7K | 203.95%1.29M | ---434K | ---159K | -43.13%-531K | 154.22%244K |
| Change In working capital | 108.50%105K | 99.37%-4K | -10.47%-633K | -174.49%-1.73M | -48.43%721K | -148.11%-1.24M | 30.43%-638K | 21.83%-573K | 388.90%2.32M | -12.52%1.4M |
| -Change in receivables | 72.52%-266K | 1,342.11%822K | -1,836.36%-191K | -86.27%373K | -24.14%1.27M | -159.24%-968K | 328.00%57K | 101.93%11K | 388.02%2.72M | 975.64%1.68M |
| -Change in prepaid assets | -19.28%201K | 107.59%52K | 454.17%266K | --0 | 3.74%388K | 17.45%249K | 0.58%-685K | -89.70%48K | 162.05%363K | -70.20%374K |
| -Change in payables and accrued expense | 223.39%306K | -260.24%-407K | -20.92%-445K | -602.93%-1.03M | -50.68%-669K | -125.59%-248K | 167.37%254K | 11.33%-368K | -88.64%205K | -186.89%-444K |
| -Change in other current liabilities | 49.44%-136K | -78.41%-471K | 0.38%-263K | -10.44%-1.07M | -29.05%-271K | -9.35%-269K | 11.41%-264K | -23.94%-264K | 10.30%-967K | 35.19%-210K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 127.45%263K | 112.51%120K | -110.22%-473K | -130.27%-1.48M | -65.05%662K | -141.05%-958K | -402.52%-959K | -165.22%-225K | 1,081.16%4.89M | 235.22%1.89M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 104.65%2K | 156.25%27K | 106.85%5K | 23.56%-159K | 125.00%5K | 56.12%-43K | 11.11%-48K | -102.78%-73K | 5.45%-208K | 23.08%-20K |
| Net PPE purchase and sale | 93.18%-6K | ---24K | --0 | 16.04%-157K | 61.42%-49K | -72.55%-88K | --0 | -100.00%-20K | -2.75%-187K | -11.40%-127K |
| Net intangibles purchase and sale | -117.78%-8K | 73.21%-15K | 61.90%-8K | ---- | ---- | 212.50%45K | -86.67%-56K | 36.36%-21K | ---- | ---- |
| Net other investing changes | --16K | 725.00%66K | 140.63%13K | 90.48%-2K | 450.00%22K | --0 | 132.00%8K | -557.14%-32K | 44.74%-21K | 0.00%4K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 104.65%2K | 156.25%27K | 106.85%5K | 23.56%-159K | 125.00%5K | 56.12%-43K | 11.11%-48K | -102.78%-73K | 5.45%-208K | 23.08%-20K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -297.30%-294K | 85.56%-134K | -4.17%-75K | 40.38%-1.15M | 87.46%-73K | 86.97%-74K | -54.67%-928K | 58.62%-72K | -85.89%-1.92M | -13.01%-582K |
| Net issuance payments of debt | -14.86%-85K | -2.70%-76K | -4.17%-75K | 55.72%-294K | 47.52%-74K | 57.47%-74K | 57.71%-74K | 58.62%-72K | 3.49%-664K | 18.50%-141K |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash dividends paid | --0 | ---- | ---- | 32.63%-799K | --0 | --0 | ---- | ---- | -325.09%-1.19M | -43.01%-399K |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | 27.03%-54K | ---- | ---- | ---- | ---- | -8.82%-74K | ---- |
| Net other financing activities | ---209K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -297.30%-294K | 85.56%-134K | -4.17%-75K | 40.38%-1.15M | 87.46%-73K | 86.97%-74K | -54.67%-928K | 58.62%-72K | -85.89%-1.92M | -13.01%-582K |
| Net cash flow | ||||||||||
| Beginning cash position | -41.35%1.43M | -67.56%1.42M | -58.65%1.96M | 138.45%4.75M | -60.38%1.37M | 36.59%2.45M | 105.92%4.38M | 138.45%4.75M | -29.69%1.99M | 75.71%3.46M |
| Current changes in cash | 97.30%-29K | 100.67%13K | -46.76%-543K | -201.02%-2.79M | -54.02%594K | -164.45%-1.08M | -474.18%-1.94M | -374.07%-370K | 427.94%2.76M | 5,283.33%1.29M |
| End cash Position | 2.55%1.41M | -41.35%1.43M | -67.56%1.42M | -58.65%1.96M | -58.65%1.96M | -60.38%1.37M | 36.59%2.45M | 105.92%4.38M | 138.45%4.75M | 138.45%4.75M |
| Free cash flow | 124.88%249K | 107.98%81K | -80.83%-481K | -134.81%-1.64M | -65.51%645K | -144.63%-1M | -452.43%-1.02M | -188.08%-266K | 1,927.16%4.7M | 249.53%1.87M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data